Invesco Ltd. 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-07 1:51 pm Sale |
2024-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Invesco Ltd. IVZ |
11,296,255 4.800% |
-1,323,514 (-10.49%) |
Filing |
| 2024-11-08 09:21 am Purchase |
2024-11-08 | 13G | ADMA Biologics, Inc. ADMA |
Invesco Ltd. IVZ |
12,619,769 5.500% |
12,619,769 (New Position) |
Filing |